Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2019-06-30
$94.27B
Positions
226
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Celgene | $0 | 0 | -78,398 | -100.00% | 0.01% | ||||||
| 2 | China Rapid Finance ADR | $0 | 0 | -300,000 | -100.00% | 0.00% | ||||||
| 3 | Lincoln Electric Hdg. | $0 | 0 | -51,216 | -100.00% | 0.00% | ||||||
| 4 | Luxoft Holding | $0 | 0 | -96,930 | -100.00% | 0.01% | ||||||
| 5 | Ship Finance Intl | $0 | 0 | -12,800 | -100.00% | 0.00% | ||||||
| 6 | SVMK INC | $0 | 0 | -1,769,756 | -100.00% | 0.04% | ||||||
| 7 | Vertex Pharmaceuticals | $0 | 0 | -424,845 | -100.00% | 0.09% |